Status:
RECRUITING
Assessing the Impact of a Leucine Enriched Whey Protein vs Isonitrogenous Whey on Muscle Protein Synthetic Responses in the Rested and Acute Post Exercise States in Older Adults
Lead Sponsor:
University of Nottingham
Conditions:
Healthy Male Volunteers Over 65
Eligibility:
MALE
65+ years
Phase:
NA
Brief Summary
Occupying \~45-55% of body mass, skeletal muscle is the largest organ of the body and plays a pivotal role in locomotion, structural support and whole-body metabolic health. Additionally, skeletal mus...
Eligibility Criteria
Inclusion
Exclusion
- A BMI \<18 or \>35 kg/m2
- Active cardiovascular, cerebrovascular or respiratory disease: e.g. uncontrolled hypertension (BP \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt, recent cardiac event, COPD, pulmonary hypertension or recent (6 mo) stroke
- Any metabolic disease
- Clotting dysfunction
- A history of, or current neurological or musculoskeletal conditions (e.g. epilepsy)
- Lactose intolerance
- Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance
Key Trial Info
Start Date :
March 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2029
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06971822
Start Date
March 14 2025
End Date
February 28 2029
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Derby Hospital Medical School
Derby, Derbyshire, United Kingdom, DE22 3NE